Case Study · Mechanism Elucidation · RNA Delivery
Vrata Therapeutics is using Urchin to unravel a mechanistic mystery by identifying novel hypotheses for iterative testing in the lab.
"We had not thought of any of these four hypotheses, and also greatly appreciate the experimental suggestions for testing. We've decided to order some [reagent] to test the second hypothesis directly."
Context
Vrata Therapeutics has developed an RNA delivery platform that localizes directly into cells via an unknown mechanism. Understanding that mechanism mattered on two fronts: allaying investor anxiety about platform risk, and uncovering genuinely new and publishable biology.
The Challenge
Mechanism elucidation is one of the hardest problems in early-stage biotech: the search space for mechanism elucidation is vast and largely unstructured. A team working manually must evaluate an enormous range of potential biological explanations against partial experimental clues — a process that is slow, prone to anchoring bias, and unlikely to surface all potential candidate hypotheses.
What Urchin Did
Urchin performed agentic search and reasoning across heterogeneous biological evidence, using the experimental clues Vrata provided as anchors. Rather than narrowing to a single explanation, Urchin systematically explored the space of mechanistic possibilities and identified four novel hypotheses consistent with the observed data — hypotheses the Vrata team had not previously considered.
Each hypothesis came with a mechanistic rationale and suggested experimental approaches for testing, giving the team an immediate, actionable research agenda.
Impact
Within one week of receiving the first Urchin report, the Vrata team had ordered reagents to begin testing one of the four hypotheses directly. The engagement moved from question to actionable experiment in days rather than months.